Penthienate: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Penthienate == | |||
[[File:Penthienate.png|thumb|right|Chemical structure of Penthienate]] | |||
Penthienate | |||
'''Penthienate''' is a [[muscarinic antagonist]] used in the treatment of various [[gastrointestinal disorders]]. It is a synthetic compound that acts by inhibiting the action of [[acetylcholine]] on [[muscarinic receptors]], thereby reducing [[smooth muscle]] contractions and [[glandular secretions]]. | |||
Penthienate is used in the treatment of a | |||
== | == Pharmacology == | ||
Penthienate is classified as an [[anticholinergic]] agent. It specifically targets the [[muscarinic acetylcholine receptor|muscarinic receptors]] in the [[parasympathetic nervous system]]. By blocking these receptors, penthienate decreases the activity of the [[vagus nerve]], leading to a reduction in [[gastric acid]] secretion and [[intestinal motility]]. | |||
=== Mechanism of Action === | |||
The primary mechanism of action of penthienate involves competitive inhibition of the muscarinic receptors. This inhibition prevents the binding of acetylcholine, a neurotransmitter responsible for stimulating the [[parasympathetic nervous system]]. As a result, the effects of acetylcholine are diminished, leading to decreased [[smooth muscle]] contractions and reduced secretions from [[exocrine glands]]. | |||
== Clinical Uses == | |||
Penthienate is used in the management of several conditions, including: | |||
* [[Peptic ulcer disease]] | |||
* [[Irritable bowel syndrome]] | |||
* [[Hyperhidrosis]] | |||
By reducing gastric acid secretion and intestinal motility, penthienate helps alleviate symptoms associated with these conditions. | |||
== Side Effects == | |||
As with other anticholinergic agents, penthienate may cause a range of side effects, including: | |||
* [[Dry mouth]] | |||
* [[Blurred vision]] | |||
* [[Constipation]] | |||
* [[Urinary retention]] | |||
* [[Tachycardia]] | |||
Patients are advised to use penthienate with caution, especially if they have pre-existing conditions such as [[glaucoma]] or [[prostatic hypertrophy]]. | |||
== Related pages == | |||
* [[Muscarinic antagonist]] | * [[Muscarinic antagonist]] | ||
* [[ | * [[Anticholinergic]] | ||
* [[Acetylcholine]] | * [[Acetylcholine]] | ||
* [[Parasympathetic nervous system]] | |||
[[Category: | [[Category:Anticholinergic agents]] | ||
[[Category:Muscarinic antagonists]] | [[Category:Muscarinic antagonists]] | ||
Latest revision as of 03:31, 13 February 2025
Penthienate[edit]

Penthienate is a muscarinic antagonist used in the treatment of various gastrointestinal disorders. It is a synthetic compound that acts by inhibiting the action of acetylcholine on muscarinic receptors, thereby reducing smooth muscle contractions and glandular secretions.
Pharmacology[edit]
Penthienate is classified as an anticholinergic agent. It specifically targets the muscarinic receptors in the parasympathetic nervous system. By blocking these receptors, penthienate decreases the activity of the vagus nerve, leading to a reduction in gastric acid secretion and intestinal motility.
Mechanism of Action[edit]
The primary mechanism of action of penthienate involves competitive inhibition of the muscarinic receptors. This inhibition prevents the binding of acetylcholine, a neurotransmitter responsible for stimulating the parasympathetic nervous system. As a result, the effects of acetylcholine are diminished, leading to decreased smooth muscle contractions and reduced secretions from exocrine glands.
Clinical Uses[edit]
Penthienate is used in the management of several conditions, including:
By reducing gastric acid secretion and intestinal motility, penthienate helps alleviate symptoms associated with these conditions.
Side Effects[edit]
As with other anticholinergic agents, penthienate may cause a range of side effects, including:
Patients are advised to use penthienate with caution, especially if they have pre-existing conditions such as glaucoma or prostatic hypertrophy.